Skip to content

MAP Pharmaceuticals, Inc.

-->-->-->-->

Investor Relations

Press Releases

All Releases
View Summary MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results
Mar 2, 2010
PDF 15.5 KB Add to Briefcase
View Summary MAP Pharmaceuticals to Present at Upcoming Healthcare Conferences
Feb 23, 2010
PDF 7.0 KB Add to Briefcase
View Summary MAP Pharmaceuticals Announces Initiation of LEVADEX(TM) Pharmacokinetics Trial
Feb 16, 2010
PDF 10.8 KB Add to Briefcase
View Summary MAP Pharmaceuticals Announces FDA will not Require a Second Pivotal Efficacy Study for LEVADEX(TM) NDA Submission
Jan 11, 2010
PDF 11.1 KB Add to Briefcase
View Summary MAP Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
Jan 6, 2010
PDF 6.8 KB Add to Briefcase
View Summary MAP Pharmaceuticals Appoints Alan Petro Vice President, Manufacturing and Technical Operations
Dec 1, 2009
PDF 10.1 KB Add to Briefcase
View Summary MAP Pharmaceuticals Secures $60 Million Committed Equity Financing Facility
Nov 12, 2009
PDF 10.3 KB Add to Briefcase
View Summary MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
Nov 11, 2009
PDF 6.8 KB Add to Briefcase
View Summary MAP Pharmaceuticals Reports Third Quarter of 2009 Financial Results
Nov 5, 2009
PDF 14.6 KB Add to Briefcase
View Summary MAP Pharmaceuticals Completes Interim Safety Review of LEVADEX(TM) Open-Label Safety Extension in More Than 400 Patients
Oct 29, 2009
PDF 10.4 KB Add to Briefcase
View Summary 'Headache' Publication Describes Potential Mechanistic Rationale for LEVADEX(TM) Favorable Adverse Event Profile
Sep 22, 2009
PDF 10.8 KB Add to Briefcase
View Summary MAP Pharmaceuticals' Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society
Sep 10, 2009
PDF 14.2 KB Add to Briefcase
View Summary MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences
Sep 2, 2009
PDF 7.0 KB Add to Briefcase
View Summary MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
Aug 6, 2009
PDF 8.1 KB Add to Briefcase
View Summary MAP Pharmaceuticals, Inc. Announces Public Offering of Common Stock
Aug 5, 2009
PDF 7.5 KB Add to Briefcase
View Summary MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results
Aug 3, 2009
PDF 13.7 KB Add to Briefcase
View Summary MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration
Jul 9, 2009
PDF 8.4 KB Add to Briefcase
View Summary MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
May 26, 2009
PDF 14.5 KB Add to Briefcase
View Summary MAP Pharmaceuticals Announces Presentations at the American Thoracic Society International Conference
May 14, 2009
PDF 7.4 KB Add to Briefcase
View Summary MAP Pharmaceuticals to Present at the Deutsche Bank Securities 34th Annual Health Care Conference
May 13, 2009
PDF 6.9 KB Add to Briefcase
Showing 1-20 of 95 Page: 1 2 3 ... 5  Next 20
= add release to Briefcase
Stock Information
NASDAQ:MAPP
$16.17  
+ 0.67
Mar 10, 2010 3:59 PM ET
Quotes delayed at least 20 minutes.
Information provided by eSignal.